Literature DB >> 29313280

The in vitro assessment of dipyridophenazine complexes in H-ras oncogene transformed rat embryo fibroblast 5RP7 cell line.

Ayse Kaplan1, Kadriye Benkli2, Ayse Tansu Koparal3.   

Abstract

Purpose The aim of this study is to detect apoptotic and cytotoxic/antiproliferative effects of a ligand substance and its metal derivatives. The substances were investigated by using an h-ras oncogene transformed rat embryo fibroblast cell line (5RP7). Methods The cytotoxic influences of dipyrido[3,2-a:2',3'c]phenazine ligand, dipyrido[3,2-a:2',3'c] phenazine-platinum(II) complex ([Pt(dppz)Cl2]) and dipyrido[3,2-a:2',3'c] phenazine-gold(III) complex ([Au(dppz)Cl2]Cl) were determined with MTT (3[4,5-dimetiltiyazol2-yl]-2,5-difeniltetrazolyum bromid) assay on 5RP7 cells. Results Dipyrido[3,2-a:2',3'c] phenazine, dipyrido[3,2-a:2',3'c] phenazine-platinum(II) complex ([Pt(dppz)Cl2]) and dipyrido[3,2-a:2',3'c] phenazine-gold(III) complexes ([Au(dppz)Cl2]Cl) caused significant increase in cytotoxicity in a dose and time dependent manner. The effects of dipyridophenazine ligand (dppz) and its metal derivatives on apoptosis were monitorized using cytotoxic dose (10 μM) DAPI fluorescent staining. It was shown that dppz and its compounds induced apoptosis. Conclusions These findings show that dpzz and its complexes can be studied as novel alternative chemotherapeutics in cancer treatment.

Entities:  

Keywords:  Apoptosis; Cytotoxicity; DAPI; Dipyridophenazine; Gold(III); Platinum(II)

Mesh:

Substances:

Year:  2018        PMID: 29313280     DOI: 10.1007/s10637-017-0559-4

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  21 in total

Review 1.  Organometallic compounds in oncology: implications of novel organotins as antitumor agents.

Authors:  Angela Alama; Bruno Tasso; Federica Novelli; Fabio Sparatore
Journal:  Drug Discov Today       Date:  2009-02-11       Impact factor: 7.851

2.  Apoptotic effects of dipyrido [3,2-a:2',3'-c] phenazine (dppz) Au(III) complex against diethylnitrosamine/phenobarbital induced experimental hepatocarcinogenesis in rats.

Authors:  Neslihan Tekin; Mehmet C Ustuner; Fahrettin Akyuz; Cansu S Ozbayer; Ozlem Aydın; Kadriye Benkli; Dilek Burukoglu; Irfan Degirmenci; Hilmi Ozden
Journal:  Mol Biol Rep       Date:  2014-04-23       Impact factor: 2.316

Review 3.  Pharmacological modulation of oncogenic Ras by natural products and their derivatives: Renewed hope in the discovery of novel anti-Ras drugs.

Authors:  Shun Ying Quah; Michelle Siying Tan; Yuan Han Teh; Johnson Stanslas
Journal:  Pharmacol Ther       Date:  2016-03-22       Impact factor: 12.310

4.  Tuning the electronic properties of dppz-ligands and their palladium(II) complexes.

Authors:  Katharina Butsch; Ronald Gust; Axel Klein; Ingo Ott; Marco Romanski
Journal:  Dalton Trans       Date:  2010-03-25       Impact factor: 4.390

5.  Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.

Authors:  S Garbisa; R Pozzatti; R J Muschel; U Saffiotti; M Ballin; R H Goldfarb; G Khoury; L A Liotta
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

6.  Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties.

Authors:  Giordana Marcon; Stefania Carotti; Marcella Coronnello; Luigi Messori; Enrico Mini; Pierluigi Orioli; Teresita Mazzei; Maria Agostina Cinellu; Giovanni Minghetti
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

7.  DNA oxidative cleavage induced by the novel peptide derivatives of 3-(quinoxalin-6-yl)alanine in combination with Cu(II) or Fe(II) ions.

Authors:  Wojciech Szczepanik; Marzena Kucharczyk-Klamińska; Piotr Stefanowicz; Anna Staszewska; Zbigniew Szewczuk; Jacek Skała; Andrzej Mysiak; Małgorzata Jezowska-Bojczuk
Journal:  Bioinorg Chem Appl       Date:  2010-03-08       Impact factor: 7.778

8.  Complexes of dichloro[2-(dimethylaminomethyl)phenyl-C1,N]gold(III), [Au(damp-C1,N)Cl2], with formylferrocene thiosemicarbazones: synthesis, structure and cytotoxicity.

Authors:  José S Casas; María V Castaño; María C Cifuentes; Juán C García-Monteagudo; Agustín Sánchez; José Sordo; Ulrich Abram
Journal:  J Inorg Biochem       Date:  2004-06       Impact factor: 4.155

9.  Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity.

Authors:  Kati-Sisko Vellonen; Paavo Honkakoski; Arto Urtti
Journal:  Eur J Pharm Sci       Date:  2004-10       Impact factor: 4.384

Review 10.  New trends for metal complexes with anticancer activity.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Curr Opin Chem Biol       Date:  2008-01-25       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.